Literature DB >> 1376065

CD20 and CD5 expression in B-chronic lymphocytic leukemia.

G E Marti1, G Faguet, P Bertin, J Agee, G Washington, S Ruiz, P Carter, V Zenger, R Vogt, P Noguchi.   

Abstract

In order to quantitate a previously noted decrease in CD20 fluorescence intensity (FI) on B-CLL lymphocytes, binding capacities [BC x 10(3) +/- 1SD = number of antibodies bound per cell] were calculated. The mean (N = 5) BC x 10(3) +/- 1SD of CD20 reagents for normal B-PBL and B-CLL lymphocytes confirmed this observation. B-PBL and B-CLL were 56 +/- 11 and 61 +/- 14, and 19 +/- 15 and 18 +/- 16, respectively, for Leu 16 and B1. Although adequate compensation standards for the determination of CD5 and CD20 coexpression are not available, qualitatively, the density of CD5 on both normal B-PBL and B-CLL is less compared to the expression of CD5 by normal T cells. CD5 expression on B-CLL seems to be linked to the lower levels of CD20, whereas CD5 expression may appear to be absent on CLL lymphocytes expressing normal levels of CD20. Levels of CD20 in B-CLL suggest involvement of one or two genes (alleles) whose decreased expression may be linked to CD5 expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376065     DOI: 10.1111/j.1749-6632.1992.tb24651.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells.

Authors:  Mohammad Luqman; Sha Klabunde; Karen Lin; Georgios V Georgakis; Anu Cherukuri; Jocelyn Holash; Cheryl Goldbeck; Xiaomei Xu; Edward E Kadel; Sang Hoon Lee; Sharon Lea Aukerman; Bahija Jallal; Natasha Aziz; Wen-Kai Weng; William Wierda; Susan O'Brien; Anas Younes
Journal:  Blood       Date:  2008-05-22       Impact factor: 22.113

2.  Levels of expression of CD19 and CD20 in chronic B cell leukaemias.

Authors:  L Ginaldi; M De Martinis; E Matutes; N Farahat; R Morilla; D Catovsky
Journal:  J Clin Pathol       Date:  1998-05       Impact factor: 3.411

3.  Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma.

Authors:  Habil Zare; Ali Bashashati; Robert Kridel; Nima Aghaeepour; Gholamreza Haffari; Joseph M Connors; Randy D Gascoyne; Arvind Gupta; Ryan R Brinkman; Andrew P Weng
Journal:  Am J Clin Pathol       Date:  2012-01       Impact factor: 2.493

4.  Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes.

Authors:  P Savage; P Cowburn; A Clayton; S Man; A McMichael; N Lemoine; A Epenetos; G Ogg
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

5.  Complement-Dependent Activity of CD20-Specific IgG Correlates With Bivalent Antigen Binding and C1q Binding Strength.

Authors:  Sina Bondza; Anita Marosan; Sibel Kara; Josephine Lösing; Matthias Peipp; Falk Nimmerjahn; Jos Buijs; Anja Lux
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

6.  <i>SF3B1</i>-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulation

Authors:  Federico Pozzo; Tamara Bittolo; Erika Tissino; Filippo Vit; Elena Vendramini; Luca Laurenti; Giovanni D'Arena; Jacopo Olivieri; Gabriele Pozzato; Francesco Zaja; Annalisa Chiarenza; Francesco Di Raimondo; Antonella Zucchetto; Riccardo Bomben; Francesca Maria Rossi; Giovanni Del Poeta; Michele Dal Bo; Valter Gattei
Journal:  Haematologica       Date:  2021-12-01       Impact factor: 9.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.